Pulmonary alveolar proteinosis induced by X-linked agammaglobulinemia: A case report. [PDF]
BACKGROUND Pulmonary alveolar proteinosis (PAP) and X-linked agammaglobulinemia (XLA) are rare diseases in children. Many theories infer that immunodeficiency can induce PAP, but these reports are almost all review articles, and there is little clinical ...
Zhang T, Li M, Tan L, Li X.
europepmc +2 more sources
SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients. [PDF]
Purpose Patients with X-linked agammaglobulinemia (XLA) are characterized by humoral impairment and are routinely treated with intravenous immunoglobulin (IVIG).
Raphael A+11 more
europepmc +2 more sources
Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series. [PDF]
of
Simard ML+4 more
europepmc +2 more sources
Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia
Encephalitis is a major cause of death worldwide. Although >100 pathogens have been identified as causative agents, the pathogen is not determined for up to 75% of cases.
Phenix-Lan Quan+15 more
doaj +6 more sources
Infections With Enterohepatic Non-H. pylori Helicobacter Species in X-Linked Agammaglobulinemia: Clinical Cases and Review of the Literature. [PDF]
The genus Helicobacter is classified into two main groups according to its habitat: gastric and enterohepatic. Patients with X-linked agammaglobulinemia (XLA) appear to be associated with invasive infection with enterohepatic non-Helicobacter pylori ...
Romo-Gonzalez C+11 more
europepmc +2 more sources
Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia. [PDF]
We read with great interest the article by Ane F Salinas et al. [1] concerning early immune responses after BNT162b2 immunization in a cohort of 41 SARS-CoV-2 infectionnaïve or previously infected patients with common variable immune deficiencies (CVID ...
Carrabba M+4 more
europepmc +2 more sources
Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant. [PDF]
Immunodeficient individuals often rely on donor-derived immunoglobulin (Ig) replacement therapy (IGRT) to prevent infections. The passive immunity obtained by IGRT is limited and reflects the state of immunity in the plasma donor population at the time ...
Lindahl H+9 more
europepmc +2 more sources
Clinical case of primary immunodeficiency: X-linked agammaglobulinemia
Aclinical case ofprimary immunodeficiency state (PIDS) is described: X-linked agammaglobulinemia in the boy of 8 years old. The results of molecular genetic studies: gene btk (ex 1-19) genome version GRCh38.p5, transcript version ENST00000308731 single ...
E. V. Kuvschinova+4 more
doaj +3 more sources
Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults [PDF]
Background X-linked agammaglobulinemia (XLA) is a humoral immunodeficiency caused by disruption of the Bruton's tyrosine kinase (BTK) gene. Typical XLA patients suffer recurrent and severe bacterial infections in childhood.
Tsuchiya Shigeru+7 more
doaj +2 more sources
Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells. [PDF]
We report a rare case of a chronic disseminated Aichi virus infection in a pediatric patient with X-linked agammaglobulinemia (XLA) that was controlled upon HLA-haploidentical hematopoietic cell transplantation (haplo-HCT).
Bekassy Z+4 more
europepmc +2 more sources